Allarity Therapeutics falls on share offering
** Drug developer Allarity Therapeutics' ALLR.O shares
down 50.8% at $4.07 premarket
** Company announces public offering of 2.5 mln shares each
of its common stock and warrants at $4.50 per share
** Purchase price at 45.6% discount to stock's last close
** Aggregate gross proceeds from offering amount to $11 mln
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic